The Internet could have been a wonderful place to nurture these friendships—and for many, it has been—but it’s led to a ...

White matter alterations within the brain are associated with cognitive impairment among individuals with and without major ...

Photos show snarled traffic and crews at the scene evaluating the extent of the damage of the sinkhole that closed a section of Interstate 80.

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...

In the December 25 episode of the tvN variety show hosted by Yoo Jae Suk and Jo Se Ho, Lee Min Ho opened up about the tragic ...

Call the Midwife returns for a new series next week and creator Heidi Thomas teased what BBC viewers can expect to see when ...

The Monument Town Council approved rules for psychedelic health centers in December, limiting them to four small areas in ...

Nelivaptan (NB-415, SSR-149415) is under development for the treatment of depression including major depressive disorder (MDD). The drug candidate targets vasopressin receptor 1B ( (V1bR). It is ...

From 2017 to 2021, pediatric depression and anxiety rates increased by 55.6% and 31.1%, respectively. Rates were higher ...

A western New York health insurance provider for seniors and the CEO of its medical analytics arm have agreed to pay a total ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

MindMed currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the biotech sector are Castle Biosciences, Inc. CSTL, CytomX Therapeutics CTMX and Spero Therapeutics SPRO, each ...